Status:
UNKNOWN
Vascular Graft Infections
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Schweizerischer Nationalfonds
Conditions:
Prosthetic Vascular Graft Infection
Eligibility:
All Genders
18+ years
Brief Summary
Background: Vascular grafts are increasingly implanted due to an increasing prevalence of atherosclerosis and diabetes, and about 1-6% of vascular procedures are complicated by infection. Mortality at...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Control patients:
- \- Vascular graft surgery (peripheral, aortic, vein)
- Case patients:
- Patients with previous primary implantation of an aortic or peripheral vascular implant and suspicion of PVGI
- Age \>18 years
- Written informed consent
- Exclusion criteria:
- Drug or alcohol abuse
- Involvement in a conflicting clinical trial (investigational drug)
- Inability to follow the procedures of the cohort, e.g. due to language problems, psychological disorders or dementia of the subject
- Known or suspected non-compliance
Exclusion
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT01821664
Start Date
May 1 2013
End Date
March 1 2023
Last Update
May 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Div of Infectious Diseases and Hospital Epidemiology
Zurich, Canton of Zurich, Switzerland, 8091